Article Details

PathMaker initiates US multicentre trial evaluating non-invasive post-stroke spasticity treatment

Retrieved on: 2022-03-12 23:33:20

Tags for this article:

Click the tags to see associated articles and topics

PathMaker initiates US multicentre trial evaluating non-invasive post-stroke spasticity treatment. View article details on hiswai:

Excerpt

RELATED ARTICLESMORE FROM AUTHOR. Artificial intelligence, cost reductions and more represent bright future for neuromodulation industry ...

Article found on: neuronewsinternational.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up